ping liu1 and jing zhang1
1department of radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, wu han, China
Synopsis
The pathogenesis of DON and diplopia is totally
different. This study use the MRI-DTI on DON and diplopia patients with good
therapeutic efficacy, the multiple DTI parameters of optic nerve were
calculated and assessed. The final results furtherly confirmed this difference.
And the statistical difference of DTI parameter changes in DON patients
validate the DTI can exactly, objectively and reliably detect the
microstructure and functional repair of optic nerve after iv MP therapy.
Introduction & Purpose:
Dysthyroid optic neuropathy (DON) and diplopia
are the common visual dysfunctions with thyroid-associated ophthalmopathy (TAO).
But the pathogenesis of them is completely different. Diplopia is the major manifestation
of extraocular muscle involvemen, while, two most widely accepted explanations
for DON are the mechanical compression of the optic nerve at the orbital apex
by the enlarged extraocular muscles1and
the ischemic mechanism2. This
study aims to observe the changes of DTI
multi-parameters value in patients with TAO and DON in comparison with patients
with TAO and diplopia after the administration of
intravenous methylprednisolone. Additionally, investigate the role of MRI-DTI
in pathogenic mechanism and neural functional recovery of
DON after pulse methylprednisolone therapy.Methods:
MRI-DTI images were prospectively viewed in 38 patients with TAO and diplopia, 15
patients with TAO and DON ,all the patients had a
good effect on the treatment of intravenous methylprednisolone(iv MP) according
to overall ophthalmic assessment. All the subjects underwent
MRI-DTI examination before and after the therapy plan. The raw DTI images were reconstructed using FUNCTOOL on GE-AW4.6 workstation. Multiple
scalar measurements of optic nerve, including fractional anisotropy (FA),
apparent diffusion coefficient (ADC), volume ratio anisotropy (VRA), relative
anisotropy (RA) anisotropy index (AI) and exponential attenuation (EA) were calculated
and analyzed by appropriate statistical methods. Results:
In patients with TAO and DON, after the intravenous methylprednisolone treatment,
the DTI parameters of optic nerve changed (Fig.1), the ADC decreased statistically (p=0.003) and FA, VRA, RA and EA increased
significantly (p=0.022, p=0.016, p=0.024, p=0.002, respectively) (Table
1). No significant difference of ADC, FA, VRA, RA, AI, EA were observed in
patients with TAO and diplopia (p=0.952, p=0.229,
p=0.329, p=0.281, p=0.228, p=0.930, respectively).Discussion:
Diffusion-tensor imaging provides useful
information regarding the axonal state and myelin degradation of the optic
nerve in visual pathway diseases3. The multiple parameters of DTI have become the
primary tools of valuable clinical applications. The FA is thought to reflect
fiber density, axonal diameter, and myelination in the white matter. Previous
study has demonstrated that increased FA of the optic nerve can differentiate thyroid
eye disease (TED) from normal controls, but also the active and inactive stages
of TED4. In our study, the iv MP treatment can control and
alleviate ocular inflammation, thus, the microstructure of damaged optic nerve
changed, axonal integrity of the optic nerve and neural functional recovered
partially, the increased FA well validate this change. The ADC reflects the
average diffusivity of water molecules. The higher ADC value reflect the
degeneration and demyelination of nerve fiber, a good therapeutic effect appeared
as a decreased ADC on MRI-DTI. In diplopia patients with TAO, impaired visual
function has nothing to do with optic nerve, even if achieve a good therapeutic
effect, the optic nerve DTI parameters had no
significant difference. Conclusion:
MRI-DTI can noninvasively differentiate the
pathogenic mechanism of DON and diplopia in TAO patients partially. The DTI
parameters can objectively and directively reflect the functional and
structural recovery of optic nerves after iv MP stratagem.Acknowledgements
This study has received funding by the National Natural Science Foundation of China (No.81301192 and No.81771793)References
1. Feldon SE, Muramatsu S, Weiner JM. Clinical classification of
Graves' ophthalmopathy. Identification of risk factors for optic neuropathy.
Arch Ophthalmol. 1984;102(10):1469-72.
2. Dosso A, Safran AB, Sunaric G, Burger A. Anterior ischemic optic
neuropathy in Graves' disease. J Neuroophthalmol. 1994;14(3):170-4.
3.Engelhorn T, Michelson G, Waerntges S, et al. Changes of radial
diffusivity and fractional anisotropy in the optic nerve and optic radiation of
glaucoma patients. TheScientificWorldJournal. 2012;2012:849632.
4.Lee H, Lee YH, Suh SI,et al. Characterizing
Intraorbital Optic Nerve Changes on Diffusion Tensor Imaging in Thyroid Eye
Disease Before Dysthyroid Optic Neuropathy. Journal of computer assisted
tomography. 2017.